Latest News & Features
Asia
Many of the world’s biggest selling drugs have lost exclusivity in recent years, presenting huge opportunities for generic drugs companies but, as LSIPR finds out, it doesn’t have to be a dead end for the innovators. 16 October 2013
Biotechnology
When the US Supreme Court decided in favour of Monsanto in its case against a soybean farmer, it clarified the patent status of certain self-replicating technologies. In Europe, the result would probably have been the same, say Steven Zeman and Heike Vogelsang-Wenke. 16 October 2013
Americas
New guidelines for the examination of biotechnology inventions in Brazil provide useful support for applicants, as Gabriel Di Blasi and Alexandre Santos explain. 16 October 2013
Big Pharma
Patent litigator Jonathan Radcliffe has left Mayer Brown to become partner at Charles Russell LLP. 16 October 2013
article
The US Court of Appeals for the Federal Circuit has denied a US company’s bid to trademark “Prevail” for medical devices used to treat obesity. 16 October 2013
Asia
Bayer has appealed against the IPAB’s compulsory licence order that allows domestic generic maker Natco Pharma to market its own version of liver and kidney cancer drug Nexavar, this time at the Mumbai High Court. 15 October 2013
Americas
After 39 years at the firm, IP litigator Trevor Cook will be leaving UK-based Bird & Bird LLP to join Wilmer Cutler Pickering Hale and Dorr LLP in New York. 15 October 2013
Americas
US biotech company Myriad Genetics is facing claims that 14 of its patents covering tests for breast and ovarian cancer are invalid and non-infringed by Quest Diagnostics. 14 October 2013
Americas
Dow Chemical Company subsidiary Dow AgroSciences has won another lawsuit involving its Enlist weed control technology. 10 October 2013
Americas
Andrulis Pharmaceuticals Corp has accused Celgene Corp of infringing and inducing the infringement of one of its patents related to a method of treating cancer. 8 October 2013